Oxford Cannabinoid Technologies (“OCT” or “the Company”) is pleased to announce the successful completion of ‘proof of concept’ of its
Chill Brands The CBD and vaping retailer Chill Brands has voted to oust two of its longest-standing directors as
Last week, UK biotechnology firm Oxford Cannabinoid Technologies (OCT), one of the first cannabis companies in history to list on
Synbiotic German cannabis group SynBiotic has capitalised on the recent explosion in medical cannabis patients since the country’s landmark
MGC Pharmaceuticals / Argent BioPharma MGC Pharmaceuticals has become the latest UK-listed cannabis company to opt for a rebrand
This week, British pharmaceutical cannabis firm Oxford Cannabinoid Technologies (OCT) announced that the ‘final dose’ in its crucial Phase I
Akanda Akanda unveiled its unaudited financial figures for the six months to the end of June 2022, two weeks after
Oxford Cannabinoid Technologies Oxford Cannabinoid Technologies (OCT) has seen its share price jump by more than 20% this week after
AFTER a month of relatively positive upwards trajectory for many European cannabis stocks, this week has seen a return to
OXFORD Cannabinoid Technologies Holdings plc (LSE: OCTP, OTCQB: OCTHF), the pharmaceutical company developing prescription cannabinoid medicines targeting the US$ multi-billion
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
